Back to Search
Start Over
A224 Lenalidomide, Bortezomib, and Dexamethasone Has Notable Activity in High-Risk First-Line Myeloma
- Source :
- Clinical Lymphoma and Myeloma; September 2009, Vol. 9 Issue: 6 pS38-S38, 1p
- Publication Year :
- 2009
Details
- Language :
- English
- ISSN :
- 15579190 and 19380712
- Volume :
- 9
- Issue :
- 6
- Database :
- Supplemental Index
- Journal :
- Clinical Lymphoma and Myeloma
- Publication Type :
- Periodical
- Accession number :
- ejs29005890
- Full Text :
- https://doi.org/10.1016/S1557-9190(11)70510-8